Novo Nordisk A/S (BVMF:N1VO34)

Novo Nordisk Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,084,204	1,251,461	2,380,287	2,239,577	1,609,379	1,427,474
Market Cap Growth	-49.41%	-47.42%	6.28%	39.16%	12.74%	69.53%
Enterprise Value	1,170,073	1,310,889	2,364,911	2,224,424	1,600,641	1,409,030
Last Close Price	31.15	35.98	66.14	60.78	42.69	-
PE Ratio	12.22	14.11	27.45	37.19	38.16	35.07
PS Ratio	4.05	4.68	9.55	13.40	11.97	11.90
PB Ratio	6.45	7.45	19.32	29.21	25.38	23.68
P/TBV Ratio	19.57	22.58	84.87	67.43	65.10	60.74
P/FCF Ratio	21.24	24.51	37.56	37.45	31.75	34.42
P/OCF Ratio	10.51	12.13	22.92	28.58	26.86	30.45
EV/Sales Ratio	4.59	4.90	9.49	13.31	11.91	11.74
EV/EBITDA Ratio	9.15	9.88	18.91	27.92	25.98	25.93
EV/EBIT Ratio	10.08	10.77	19.83	29.53	27.87	27.92
EV/FCF Ratio	22.92	25.68	37.32	37.20	31.57	33.97
Debt / Equity Ratio	0.68	0.68	0.72	0.25	0.31	0.38
Debt / EBITDA Ratio	0.85	0.85	0.70	0.24	0.31	0.41
Debt / FCF Ratio	2.22	2.22	1.39	0.33	0.39	0.55
Asset Turnover	0.61	0.61	0.75	0.84	0.81	0.83
Inventory Turnover	1.20	1.20	1.20	1.26	1.29	1.24
Quick Ratio	0.54	0.54	0.53	0.62	0.67	0.65
Current Ratio	0.80	0.80	0.74	0.82	0.90	0.86
Return on Equity (ROE)	60.70%	60.70%	80.77%	88.07%	72.00%	71.24%
Return on Assets (ROA)	17.43%	17.43%	22.26%	23.55%	21.69%	21.81%
Return on Invested Capital (ROIC)	41.13%	42.60%	68.23%	88.56%	73.42%	67.98%
Return on Capital Employed (ROCE)	43.00%	43.00%	56.00%	72.30%	62.80%	62.30%
Earnings Yield	8.18%	7.09%	3.64%	2.69%	2.62%	2.85%
FCF Yield	4.71%	4.08%	2.66%	2.67%	3.15%	2.90%
Dividend Yield	2.79%	28.16%	14.80%	11.13%	11.03%	-
Payout Ratio	50.53%	50.53%	43.71%	37.96%	45.57%	45.05%
Buyback Yield / Dilution	0.34%	0.34%	0.71%	1.10%	1.34%	1.58%
Total Shareholder Return	3.14%	28.50%	15.50%	12.23%	12.37%	1.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.